Having not been part of Pharmaxis's long history, was this just a re-application to the PBS? i.e. they have been down this road before and have just been knocked back again?
If this is the case then if there is weakness tomorrow it may be another great opportunity to top up having Europe being approved and the US in process
bronchitol declined by pbs , page-9
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
